Johnson & Johnson Ordered to Pay $15M in Talc Cancer Case
A Connecticut jury found J&J liable for a man's mesothelioma, adding to the company's ongoing talc-related legal challenges.
- Evan Plotkin, who developed mesothelioma allegedly from J&J's talc powder, was awarded $15 million by a Connecticut jury.
- The jury also decided J&J should pay additional punitive damages, with the amount to be determined later.
- J&J plans to appeal the decision, citing what it claims are 'erroneous' rulings that excluded key case facts.
- The verdict comes amid J&J's efforts to settle over 62,000 claims related to ovarian and other cancers through a $9 billion bankruptcy settlement.
- J&J withdrew its talc-based products from the U.S. market in 2020, maintaining that its products are safe and asbestos-free.